| 中文名 | 洛匹那韦代谢物M1 |
|---|---|
| 英文名 | Lopinavir Metabolite M-1 |
| 中文别名 |
洛匹那韦代谢物
洛匹那韦相关杂质 洛匹那韦IP杂质E(杂质22) |
| 英文别名 |
(aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-de
(αS)-N-[(1S,3S,4S)-4-[[(2,6-DiMethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylMethyl)pentyl]tetrahydro-α-(1-Methylethyl)-2,4-dioxo-1(2H)-pyriMidineacetaMi- de (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- d 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-, (αS) Lopinavir Impurity 22 Lopinavir IP Impurity E (S)-N-((2S,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-methylbutanamide Lopinavir 4-Oxo Analog/ Lopinavir Metabolite M1 (2S,3S,5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydropyrimid-2,4-dionyl)-3-methyl-butanoyl)amino-1,6-diphenylhexane (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- de 4-Oxo-ABT-378 Lopinavir IP Impurity E( Impurity 22) (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-d |
| 描述 | Lopinavir Metabolite M-1 是 Lopinavir 的活性代谢产物,以 0.7 pM 的 Ki 值抑制 HIV 蛋白酶。Lopinavir Metabolite M-1 在体外具有抗病毒活性。 |
|---|---|
| 相关类别 | |
| 靶点 |
IC50: 0.7 pM (HIV Protease)[1] |
| 体外研究 | 洛比那韦代谢产物M-1对MT-4细胞具有抗病毒活性,EC50为1.413μM[1]。 |
| 参考文献 |
| 分子式 | C37H46N4O6 |
|---|---|
| 分子量 | 642.78400 |
| 精确质量 | 642.34200 |
| PSA | 137.07000 |
| LogP | 5.63440 |
| 折射率 | 1.582 |
| 上游产品 6 | |
|---|---|
| 下游产品 0 | |